1. Huahai Pharmaceutical: It is a well-known domestic pharmaceutical company with profound technical accumulation and rich production experience in the field of cardiovascular APIs. The company's main products include cardiovascular APIs such as prils and sartans. Its telmisartan API is an angiotensin II receptor antagonist. It achieves comprehensive protection of the cardiovascular system through multiple mechanisms such as blocking the binding of angiotensin II to its receptor, inhibiting angiotensin converting enzyme, and reducing aldosterone secretion. It can effectively regulate blood pressure levels, prevent pathological changes such as myocardial hypertrophy and left ventricular remodeling caused by hypertension, and maintain the health and stability of the heart structure2.
2. Nanjing Chenruisheng Biopharmaceutical Technology Co., Ltd.: The company produces levosimendan API. Levosimendan is the first listed variety in the new generation of cardiotonic drugs - calcium sensitizers, and is mainly used in clinical treatment of various acute heart failure symptoms. It mainly increases the sensitivity of myocardial contractile proteins to Ca2+ and opens the K+ channels sensitive to adenosine triphosphate (ATP) enzymes on the cell membrane, thereby increasing myocardial contractility while dilating peripheral blood vessels and coronary arteries, reducing the heart's preload and postload, and can effectively enhance myocardial contractility, but does not increase myocardial oxygen consumption, and has no significant effect on heart rate. It can effectively relieve symptoms while improving prognosis and reducing mortality.
3. Hangzhou Kelai Biopharmaceutical Technology Co., Ltd.: Supply of Telmisartan API. Telmisartan, as a specific angiotensin II receptor (ATⅠ type) antagonist, can be used to treat essential hypertension and reduce cardiovascular risk. It is suitable for patients aged 55 years and above who are at high risk of severe cardiovascular events and cannot receive angiotensin converting enzyme (ACE) inhibitor treatment.
4.Zhejiang Fengfu Pharma Co.,Limited
Zhejiang Fengfu Pharma Co.,Limited engaged in the development, production and marketing of pharmaceutical products, food ingredients, vitamins, intermediates and chemicals.
Fengfu Pharma,headquartered in Hangzhou, China, with 3 production bases in Shandong, Zhejiang and Hebei separately, which have many years of experience in the production of APIs, vitamins and chemical products. These facilities have been certified GMP, ISO, FAMI-QS, KOSHER, HALAL, etc. We have complete control over our product development, design, and manufacturing processes, thanks to our advanced equipment, methods, and inspection facilities.
With key competencies in pharmaceuticals and food health, Fengfu Pharma has established extensive business networks around the world. We have Strategic Marketing Partners in Mumbai and Dubai respectively. We are ready to provide you with our best products and services.